HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by D’Costa, J. Articles by Arya, S. K. Search for Related Content PubMed PubMed Citation Articles by D’Costa, J. Articles by Arya, S. K. Agricola Articles by D’Costa, J. Articles by Arya, S. K.

Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation

Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute, Building 37, Room 5E10, National Institutes of Health, Bethesda, MD 20892, USA¹

Author for correspondence: Suresh Arya. Fax +1 301 496 5839. e-mail aryas{at}dc37a.nci.nih.gov

Retroviral vectors provide the means for gene transfer with long-term expression. The lentivirus subgroup of retroviruses, such as human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2), possesses a number of regulatory and accessory genes and other special elements. These features can be exploited to design vectors for transducing non-dividing as well as dividing cells with the potential for regulated transgene expression. Encapsidation of the transgene RNA in lentiviral vectors is determined by the leader sequence-based multipartite packaging signal. Embedded in the packaging signal is a major splice donor site that, this study shows, is not by itself essential for transgene expression or encapsidation. We designed HIV-2 vectors that contained all the sequence elements thought to be necessary and sufficient for vector RNA encapsidation. Unexpectedly, despite abundant expression, only a small fraction of the transgene RNA was encapsidated and the titre of the vector was low. Redesign of the vector with a mutant splice donor resulted in increased vector RNA encapsidation and yielded vectors with high titre. Inefficient encapsidation by the conventionally designed vector was not due to suboptimal Rev responsive element (RRE)–Rev function. Varying the length of RRE in the vector did not change vector RNA encapsidation, nor did the introduction of a synthetic intron into the mutant vector. The vector RNA with the intact splice donor may have been excessively spliced, decreasing the amount of packageable RNA. A titre of 10⁵ transducing units (TU)/ml was readily obtained for vectors with the neo or GFP transgene, and the vector could be concentrated to a titre of 1–5x10⁷  TU/ml.

This article has been cited by other articles:

				A. C. Logan, D. L. Haas, T. Kafri, and D. B. Kohn Integrated Self-Inactivating Lentiviral Vectors Produce Full-Length Genomic Transcripts Competent for Encapsidation and Integration J. Virol., August 15, 2004; 78(16): 8421 - 8436. [Abstract] [Full Text] [PDF]

				M. Butsch and K. Boris-Lawrie Destiny of Unspliced Retroviral RNA: Ribosome and/or Virion? J. Virol., March 7, 2002; 76(7): 3089 - 3094. [Full Text] [PDF]

				J. P. O'Rourke, G. C. Newbound, D. B. Kohn, J. C. Olsen, and B. A. Bunnell Comparison of Gene Transfer Efficiencies and Gene Expression Levels Achieved with Equine Infectious Anemia Virus- and Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors J. Virol., February 1, 2002; 76(3): 1510 - 1515. [Abstract] [Full Text] [PDF]